CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating Activities
Net income	$ 397.0	$ 355.0
Adjustments to reconcile net income to net cash flows provided by (used in) operating activities:
Depreciation, amortization and accretion	55.0	49.0
Provision for credit losses	67.1	57.5
Deferred tax expense (benefit)	17.0	17.0
Loans originated for sale	(1,225.0)	(1,109.0)
Loans sold	1,182.0	1,069.0
Net (gains) losses on sale of loans	(12.0)	(10.0)
Net change in:
Interest receivable	(1.0)	(6.0)
Interest payable	(3.0)	3.0
Bank owned life insurance, excluding purchases	(7.0)	3.0
Other, net	(116.0)	(112.0)
Net cash flows provided by (used in) operating activities	354.0	316.0
Investing Activities
Net change in loans and leases, excluding sales and transfers	(1,073.0)	(1,857.0)
Debt securities available for sale:
Purchases	(625.0)	(864.0)
Maturities/payments	560.0	707.0
Debt securities held to maturity:
Purchases	(386.0)	(187.0)
Maturities/payments	324.0	283.0
Increase in premises and equipment	(77.0)	(91.0)
Net proceeds from sales of portfolio loans	5.0	776.0
Net cash flows provided by (used in) investing activities	(1,272.0)	(1,233.0)
Financing Activities
Demand (non-interest-bearing and interest-bearing) and savings accounts	1,279.0	605.0
Time deposits	54.0	1,453.0
Short-term borrowings	649.0	(944.0)
Proceeds from issuance of long-term borrowings	529.0	877.0
Repayment of long-term borrowings	(1,444.0)	(335.0)
Redemption of preferred stock	0.0	(111.0)
Repurchases of common stock	(32.0)	(3.0)
Cash dividends paid:
Preferred stock	0.0	(2.0)
Common stock	(131.0)	(131.0)
Other, net	8.0	10.0
Net cash flows provided by (used in) financing activities	912.0	1,419.0
Net Increase (Decrease) in Cash and Cash Equivalents	(6.0)	502.0
Cash and cash equivalents at beginning of period	2,419.0	1,576.0
Cash and Cash Equivalents at End of Period	$ 2,413.0	$ 2,078.0